AnGes, Inc. (TYO:4563)
Japan
· Delayed Price · Currency is JPY 64.00
-1.00 (-1.54%)
May 21, 2025, 3:30 PM JST
AnGes Revenue
AnGes had revenue of 169.00M JPY in the quarter ending March 31, 2025, with 49.56% growth. This brings the company's revenue in the last twelve months to 699.00M, up 180.72% year-over-year. In the year 2024, AnGes had annual revenue of 643.00M with 323.03% growth.
Revenue (ttm)
699.00M
Revenue Growth
+180.72%
P/S Ratio
31.01
Revenue / Employee
12.71M
Employees
55
Market Cap
21.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 643.00M | 491.00M | 323.03% |
| Dec 31, 2023 | 152.00M | 85.00M | 126.87% |
| Dec 31, 2022 | 67.00M | 3.00M | 4.69% |
| Dec 31, 2021 | 64.00M | 25.00M | 64.10% |
| Dec 31, 2020 | 39.00M | -287.00M | -88.04% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,581.55B |
| HOYA Corporation | 869.37B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |